Indication
Post-acute Sequelae of SARS-CoV-2 Infection
1 clinical trial
3 products
Clinical trial
Selective Trial Of Paxlovid for PASC (STOP-PASC): Randomized Double-Blind Placebo-Controlled Pilot Trial of Paxlovid for the Treatment of PASCStatus: Completed, Estimated PCD: 2023-08-14
Product
NirmatrelvirProduct
PlaceboProduct
Ritonavir